11 Feb 2026 09:01 CET

Issuer

ArcticZymes Technologies ASA

ArcticZymes Technologies ASA invites investors, analysts and other stakeholders
to its Capital Markets Day on 6 March 2026, 09:00-12:00
CET (registration and coffee from 08:30).

The event will take place at Nordea's offices, Smålandsgatan 17, Stockholm,
Sweden but can also be joined virtually.

Building a Scalable Enzyme Platform
At the Capital Markets Day, management will present how ArcticZymes has
completed its commercial transformation and is now focused on scaling its enzyme
platform across high-growth biomanufacturing and molecular tool markets.

The session will address:

· Structural market drivers in advanced therapies, viral vectors, RNA
workflows and metagenomics
· ArcticZymes' differentiated positioning and customer economics
· The strategy to accelerate innovation and strengthen the product pipeline
· Commercial traction and customer adoption dynamics
·
The company's growth ambition supported by organic expansion and selective value
-accretive M&A
· Customer presentation on how ArcticZymes products are used in real life

The objective of the day is to provide greater transparency into the company's
growth logic, scalability and long-term value creation potential.

Presentations will be delivered by:

· Michael Akoh, CEO
· Paul Blackburn, CCO
· Børge Sørvoll, CFO
· Steve Dey, Director of Product Management & Marketing

In addition, we will hear directly from a customer representative, Rafi Ahmad,
University of Southampton / University of Inland Norway, who will discuss the
role of ArcticZymes' enzymes in metagenomics workflows.

Participation

To attend in person, please register by emailing ir@arcticzymes.com,
as seating is limited.

A live webcast will be available at www.arcticzymes.com and via Firmwire:
https://www.finwire.tv/webcast/arcticzymes-technologies/cmd/

The webcast will include a Q&A session with the opportunity to submit questions
digitally.

We look forward to welcoming you to Stockholm.

For further information, please contact:

Børge Sørvoll
CFO
ir@arcticzymes.com
+47 952 90 187


Source

ArcticZymes Technologies ASA

Provider

Oslo Børs Newspoint

Company Name

ARCTICZYMES TECHNOLOGIES

ISIN

NO0010014632

Symbol

AZT

Market

Euronext Oslo Børs